Cargando…
Medicare claims analysis of agents used to manage dementia-related psychosis: a treatment pattern study
Currently, no agents are approved in the USA to treat dementia-related psychosis. After failure of a nonpharmacologic approach to treatment, antipsychotics or divalproex is often prescribed. We characterized existing treatment patterns in patients with dementia-related psychosis. Medicare claims dat...
Autores principales: | Rashid, Nazia, Wetmore, James B., Irfan, Muna, Peng, Yi, Abler, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams And Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969840/ https://www.ncbi.nlm.nih.gov/pubmed/35357330 http://dx.doi.org/10.1097/YIC.0000000000000401 |
Ejemplares similares
-
Economic Evaluation of Healthcare Resource Utilization and Costs for Newly Diagnosed Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2022) -
Real-World Medication Treatment Patterns for Long-Term Care Residents with Dementia-Related Psychosis
por: Rashid, Nazia, et al.
Publicado: (2021) -
Burden of illness among patients with dementia-related psychosis
por: Frazer, Monica, et al.
Publicado: (2021) -
Comparative Outcomes of Commonly Used Off-Label Atypical Antipsychotics in the Treatment of Dementia-Related Psychosis: A Network Meta-analysis
por: Yunusa, Ismaeel, et al.
Publicado: (2022) -
Gout and dementia in the elderly: a cohort study of Medicare claims
por: Singh, Jasvinder A., et al.
Publicado: (2018)